Dottorato in Fisiopatologia Medica

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target

Koni M, Castellano I, Venturelli E, Sarcinella A, Lopatina T, Grange C, Cedrino M, Femminò S, Cossu-Rocca P, Orrù S, D'Ascenzo F, Cotellessa I, Tampieri C, Debernardi C, Cugliari G, Matullo G, Camussi G, De Miglio MR, Brizzi MF. 

IL-3 signalling in the tumour microenvironment shapes the immune response via tumour endothelial cell-derived extracellular vesicles.

Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple negative breast cancer via extracellular vesicle reprogramming

Tatiana Lopatina, Cristina Grange, Claudia Cavallari, Victor Navarro-Tableros, Giusy  Lombardo, Arturo Rosso, Massimo Cedrino, Margherita Alba Carlotta Pomatto, Malvina Koni,  Francesca Veneziano, Isabella Castellano, Giovanni Camussi, and Maria Felice Brizzi

The Wnt Signalling Pathway: A Tailored Target in Cancer

Malvina Koni, Veronica Pinnarò, Maria Felice Brizzi

Redox-responsive MRI probes to follow-up hypoxia within cell-embedding hydrogels

Padovan, V. Catanzaro, F. Capuana, C. Grange, M. Koni, C. Carrera, N. Filipovic, M. Stevanovic, G. Digilio.

2nd Workshop EVIta Connect: Fostering collaboration

Molecular Biotechnology Center (MBC), Turin (Italy)

Oral presentation

TEC-EVs, nano players interfering with the immune system in a 4T1 mouse triple-negative breast cancer (TNBC) model

21st International Conference On Progress In Vaccination Against Cancer (Pivac-22)

Molecular Biotechnology Center (MBC), Turin (Italy)

Poster presentation

“Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target”

2nd EVIta Symposium

Lucca, (Italy)

Oral presentation

"nEVs increase tumor metastasis in a 4T1 mouse triple-negative breast cancer (TNBC) model"

Open Science and FAIR Data